D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.23% |
| 2 | Consumer Discretionary | 11.75% |
| 3 | Healthcare | 9.92% |
| 4 | Financials | 7.86% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
2276
CALL
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.39M | ﹤0.01% |
30,100
+20,000
| +198% | +$1.19M |
|
2277
CALL
PG&E
PCG
$39B
| $2.39M | ﹤0.01% |
220,000
| – | – |
|
2278
CALL
XPO
XPO
$23.4B
| $2.39M | ﹤0.01% |
86,742
| – | – |
|
2279
CALL
Tandem Diabetes Care
TNDM
$1.27B
| $2.38M | ﹤0.01% |
40,000
-900
| -2% | -$55.5K |
|
2280
PUT
Western Union
WU
$2.53B
| $2.38M | ﹤0.01% |
+89,000
| New | +$2.31M |
|
2281
PUT
Wheaton Precious Metals
WPM
$49.7B
| $2.38M | ﹤0.01% |
80,000
+50,000
| +167% | +$1.37M |
|
2282
InterContinental Hotels
IHG
$23.8B
| $2.37M | ﹤0.01% |
34,507
-45,823
| -57% | -$2.85M |
|
2283
Truist Financial
TFC
$63.9B
| $2.36M | ﹤0.01% |
41,924
+36,024
| +611% | +$1.95M |
|
2284
Four Corners Property Trust
FCPT
$2.89B
| $2.36M | ﹤0.01% |
83,574
-72,365
| -46% | -$2.02M |
|
2285
PJT Partners
PJT
$4.26B
| $2.36M | ﹤0.01% |
52,211
-732
| -1% | -$30.7K |
|
2286
CALL
Tractor Supply
TSCO
$16.3B
| $2.35M | ﹤0.01% |
126,000
| – | – |
|
2287
Equifax
EFX
$22B
| $2.35M | ﹤0.01% |
+16,800
| New | +$2.33M |
|
2288
CALL
Ionis Pharmaceuticals
IONS
$8.93B
| $2.35M | ﹤0.01% |
38,900
| – | – |
|
2289
PUT
Teradata
TDC
$2.88B
| $2.35M | ﹤0.01% |
87,700
+57,700
| +192% | +$1.6M |
|
|
TCS
2290
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $2.35M | ﹤0.01% |
37,079
-15,225
| -29% | -$965K |
|
2291
PUT
G-III Apparel Group
GIII
$1.54B
| $2.35M | ﹤0.01% |
70,000
-60,000
| -46% | -$1.7M |
|
2292
Atmos Energy
ATO
$29.7B
| $2.33M | ﹤0.01% |
+20,870
| New | +$2.29M |
|
|
SCPE.U
2293
DELISTED
SC Health Corporation Units, each consisting of one Class A ordinary share, $0.0001 par value, and o
SCPE.U
| $2.33M | ﹤0.01% |
225,000
| – | – |
|
2294
CALL
Xerox
XRX
$345M
| $2.33M | ﹤0.01% |
63,200
+29,100
| +85% | +$1.02M |
|
2295
CALL
Ross Stores
ROST
$80.8B
| $2.33M | ﹤0.01% |
+20,000
| New | +$2.25M |
|
|
CLDR
2296
CALL
DELISTED
Cloudera, Inc.
CLDR
| $2.33M | ﹤0.01% |
200,000
| – | – |
|
2297
PUT
iQIYI
IQ
$1.19B
| $2.32M | ﹤0.01% |
110,000
-382,400
| -78% | -$7.03M |
|
2298
Jabil
JBL
$30.1B
| $2.32M | ﹤0.01% |
56,114
-206,661
| -79% | -$7.93M |
|
|
SAGE
2299
PUT
DELISTED
Sage Therapeutics
SAGE
| $2.31M | ﹤0.01% |
32,000
| – | – |
|
2300
PUT
Eastman Chemical
EMN
$7.69B
| $2.31M | ﹤0.01% |
29,100
+20,700
| +246% | +$1.59M |
|
Similar funds
D.E. Shaw & Co's Q4 2019 Portfolio in Review
As of Q4 2019, D.E. Shaw & Co held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- D.E. Shaw & Co added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- D.E. Shaw & Co's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- D.E. Shaw & Co fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- D.E. Shaw & Co opened 572 new positions and closed 412 in Q4 2019.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.